drugset / Trial / NCT05006911
Pilocarpine, Brimonidine, Oxymetazoline (PBO) Compound to Control Presbyopia Symptoms
NaSingle-groupOpen-labelTreatment
Summary
Safety and Efficacy of Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac (PBOHB) ophthalmic compound to improve uncorrected near vision in healthy presbyopic patients one hour after instillation.
Timeline
- Start
- 2021-08-14
- Primary completion
- 2021-09-01
- Completion
- 2021-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Unknown | — | — |
| Subject | Bromfenac | Other / unclassified | — | — |
| Subject | Hyaluronic Acid | Other / unclassified | — | — |
| Subject | Oxymetazoline | Other / unclassified | — | — |
| Subject | Pilocarpine | Unknown | — | — |